# FDA recall D-160-2013

> **Upsher Smith Laboratories, Inc.** · Class II · drug recall initiated 2012-11-20.

## Product

Propranolol Hydrochloride Extended-release Capsules, USP, 80 mg, 100 Capsules, Rx only, Manufactured for Upsher Smith Laboratories, Inc Minneapolis MN 55447  ---  NDC 0245-0085-11, UPC 3 0245-0085-11 9

## Reason for recall

Failed Dissolution Test Requirements

## Distribution

FL, NJ.

## Key facts

- **Recall number:** D-160-2013
- **Recalling firm:** Upsher Smith Laboratories, Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2012-11-20
- **Report date:** 2013-02-20
- **Termination date:** 2013-07-12

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Maple Grove, MN, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-160-2013

## Citation

> AI Analytics. FDA recall D-160-2013. Retrieved 2026-05-26 from https://api.ai-analytics.org/recall/D-160-2013. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*